OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
María Pagnon de la Vega, Carl Näslund, RoseMarie Brundin, et al.
BMC Genomics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 12
María Pagnon de la Vega, Carl Näslund, RoseMarie Brundin, et al.
BMC Genomics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
Natural antioxidants that act against Alzheimer’s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Role of TREM2 in immune and neurological diseases: Structure, function, and implications
Peng Yin, Zhaoliang Su, Xiaozheng Shu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113286-113286
Closed Access | Times Cited: 4
Peng Yin, Zhaoliang Su, Xiaozheng Shu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113286-113286
Closed Access | Times Cited: 4
COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer disease
Marwan N. Sabbagh, Boris Decourt
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 987-993
Open Access | Times Cited: 19
Marwan N. Sabbagh, Boris Decourt
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 987-993
Open Access | Times Cited: 19
Recent Progress in Research on Mechanisms of Action of Natural Products against Alzheimer’s Disease: Dietary Plant Polyphenols
Yi Wang, Kaiyue Wang, Junyuan Yan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13886-13886
Open Access | Times Cited: 17
Yi Wang, Kaiyue Wang, Junyuan Yan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13886-13886
Open Access | Times Cited: 17
Clinical Significance of Early-Onset Alzheimer’s Mutations in Asian and Western Populations: A Scoping Review
Prevathe Poniah, Aswir Abd Rashed, Julaina Abdul Jalil, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 345-345
Open Access
Prevathe Poniah, Aswir Abd Rashed, Julaina Abdul Jalil, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 345-345
Open Access
Recent research advances in young-onset dementia
Samantha Loi, Yolande A.L. Pijnenburg, Dennis Velakoulis
Current Opinion in Psychiatry (2022) Vol. 36, Iss. 2, pp. 126-133
Closed Access | Times Cited: 13
Samantha Loi, Yolande A.L. Pijnenburg, Dennis Velakoulis
Current Opinion in Psychiatry (2022) Vol. 36, Iss. 2, pp. 126-133
Closed Access | Times Cited: 13
Prediction of Alzheimer’s Disease by a Novel Image-Based Representation of Gene Expression
Habil Kalkan, Umit Murat Akkaya, Güldal İnal Gültekin, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1406-1406
Open Access | Times Cited: 10
Habil Kalkan, Umit Murat Akkaya, Güldal İnal Gültekin, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1406-1406
Open Access | Times Cited: 10
Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
Roshni C. Lalwani, Claude‐Henry Volmar, Claes Wahlestedt, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3232-3232
Open Access | Times Cited: 6
Roshni C. Lalwani, Claude‐Henry Volmar, Claes Wahlestedt, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3232-3232
Open Access | Times Cited: 6
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
María Pagnon de la Vega, Stina Syvänen, Vilmantas Giedraitis, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
María Pagnon de la Vega, Stina Syvänen, Vilmantas Giedraitis, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Rare Pathogenic Variants in Pooled Whole-Exome Sequencing Data Suggest Hyperammonemia as a Possible Cause of Dementia Not Classified as Alzheimer’s Disease or Frontotemporal Dementia
Sena Karachanak-Yankova, Dimitar Serbezov, G Antov, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 753-753
Open Access
Sena Karachanak-Yankova, Dimitar Serbezov, G Antov, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 753-753
Open Access
Rare Pathogenic Variants in Pooled Whole-Exome Sequencing Data Suggest Ciliary Defects and Hyperammoniemia as Possible Causes of Dementia Not Classified as Alzheimer’s Disease or Frontomteporal Dementia
Sena Karachanak-Yankova, Dimitar Serbezov, Mikaela Stancheva, et al.
(2024)
Open Access
Sena Karachanak-Yankova, Dimitar Serbezov, Mikaela Stancheva, et al.
(2024)
Open Access
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
Emma Barrett, Gabrielle Ivey, Adam Cunningham, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Emma Barrett, Gabrielle Ivey, Adam Cunningham, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
